Institute of Clinical and Molecular Virology

P172: Decoding the Impact of Human Cytomegalovirus Glycoprotein B Variants on Viral Fusion March 1, 2025 - Feb. 28, 2026 BayFrance FK-24-2024 Jan. 30, 2025 - Jan. 29, 2026 P165-OA: Lipid nanoparticles for targeted delivery of HIV-1 antigens and genetic immunomodulators Jan. 1, 2025 - Dec. 31, 2025 A095: The 2’-O-methylation of viral RNA regulates innate immune sensing by MDA5 Jan. 1, 2023 - Dec. 31, 2025 A096: Molecular and functional analysis of immune/ intestinal epithelial cell-interaction during CMV infection Jan. 1, 2023 - Dec. 31, 2025 J100: A TRM-inducing mucosal vaccination against lung-metastasizing cancer Jan. 1, 2023 - Dec. 31, 2025 Interferenz mit der Spaltung des viralen Proteins p12: Auswirkungen auf Transmission und Persistenz des onkogenen Retrovirus Humanes T-Zell-Leukämie-Virus Typ 1 (VI-Pfleger-Stiftung_virale Protein p12) Aug. 1, 2024 - July 31, 2025 Inducing long-lasting HIV Env-specific antibody responses by intrastructural help Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention Oct. 1, 2019 - March 31, 2024 P099: Influence of the translocated microbiome on the TCR repertoire April 16, 2022 - Jan. 15, 2024 Identification of host restriction factors against Human T-cell leukemia virus (BFHZ_Mobilitätsbeih._ER-Montpellier) Aug. 5, 2014 - Dec. 31, 2023